A comparative study of OAE(otoacoustic emission) and BERA(Brainstem evoked responseaudiometry)as a screening of hearing loss among the patients for hearingassesment in ENT OPD(less than 12 years)

Department of Otorhinolaryngology0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: 4- Measurement and Monitoring

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: 4- Measurement and Monitoring
Sponsor: Department of Otorhinolaryngology
Status: Not yet recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

3 years ago

Study Type

Observational

Investigators

Sponsor

Department of Otorhinolaryngology

Eligibility Criteria

Inclusion Criteria

•1\.Children age group \<12 years of age
•2\.Patient comes in ENT
•OPD including ear complain
•3\.Children reffered by pediatrician
•on susoicious of hearing loss/speech delay/presence of any high risk
•4\.Chlidren brought by parents suspicious of hearing loss or speech delay

Exclusion Criteria

•1\.Patient with absent external auditory canal,meatal
•atresia,anomalies of the external where probe insertion not possible
•2\.Tympanic membrane perforation
•3\.Children with purulent ear discharge,acute suppurative otitis media
•conditions of ear like external impacted wax were included in study after the condition was treated

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting

Not Applicable

Checking the effectiveness of a new hearing assessment (Oto-acoustic Emission) in identifying hearing loss caused due to Cisplatin (widely used as part of cancer treatment) in adult cancer patients.Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

CTRI/2023/12/060500Tata Research Administrative Council

Recruiting

Not Applicable

Checking the feasibility of a new hearing assessment tool(Oto-acoustic Emission) in identifying early and significant amount of hearing loss caused due to Cisplatin (widely used as a chemotherapy drug in cancer patients) chemotherapy in pediatric cancer patients.

CTRI/2023/03/051221Tata Research Administrative Council

Completed

Not Applicable

Acoustic emission analysis for diagnosis of osteoarthritis of the knee compared to magnetic resonance imaging - a pilot studyM17Gonarthrosis [arthrosis of knee]

DRKS00004671Hochschule für Gesundheit29

Not yet recruiting

Not Applicable

To assess hearing loss in high risk newborns using 2 modalitiesHealth Condition 1: H906- Mixed conductive and sensorineuralhearing loss, bilateral

CTRI/2023/09/057677Maulana Azad Medical College and associated Lok Nayak hospital

Completed

Not Applicable

?A comparative study of the sonographic, electromyographic and functional changes following 8 weeks dynamic neuromuscular stabilization (DNS) exercises between patients with non-specific low back pain and the control groupow back pain.Other injury of lumbar spinal cordS34.1

IRCT20220310054242N1Shahid Beheshti University of Medical Sciences40